Publications
3 shownAxicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Axi-cel therapy led to significant improvements, as compared with standard care, in event-free survival and response, with the expected level of high-grade toxic effects. (Funde...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 1,797
- Institution
- KU Leuven
External Links
Identifiers
- ORCID
- 0000-0003-4719-1935
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.